VIRI Insider Trading Activity and SEC Form 4 Filings
VIRI insider trading summary
No open-market insider purchases or sales of Virios Therapeutics, Inc. (VIRI) have been reported on SEC Form 4 in the past 12 months.
Latest VIRI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 21, 2023 | William Pridgen | Insider | Buy | $20K (15,335 @ $1.30) |
| Aug 17, 2023 | Gregory Scott Duncan | Chief Executive Officer | Buy | $31K (25,000 @ $1.25) |
| Dec 8, 2022 | Richard James Whitley | Insider | Sell | $466 (1,800 @ $0.26) |
| May 23, 2022 | Angela Walsh | SVP of Finance | Buy | $9K (2,000 @ $4.58) |
| May 23, 2022 | Gregory Scott Duncan | Chief Executive Officer | Buy | $34K (7,500 @ $4.52) |
| May 18, 2022 | William Pridgen | Insider | Buy | $1K (241 @ $4.50) |
| May 18, 2022 | Richard James Whitley | Insider | Buy | $2K (500 @ $4.53) |
| May 17, 2022 | William Pridgen | Insider | Buy | $59K (13,450 @ $4.38) |
| Mar 29, 2022 | William Pridgen | Insider | Buy | $3K (600 @ $4.94) |
| Mar 23, 2022 | William Pridgen | Insider | Buy | $12K (2,197 @ $5.46) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.